Greeting From Virtue Insight,
I am happy to invite you and your colleagues to be a sponsor/ delegate for our upcoming”9th Biosimilars Congregation” The conference will be held on 22nd September 2016, The Lalit Hotel, Mumbai, India
KEY SPEAKERS:-
DHILEEP KRISHNAMURTHY, Vice President & Head Global R&D API, Piramal Life Sciences
BHASWAT CHAKRABORTY, Senior VP & Chair, Research and Development Core Committee, Cadila
ARUN BHATT, Consultant - Clinical Research & Development
PRITI THAKOR, Associate Director Medical Affairs, Merck
INDRANIL BHATTACHARYA, Associate Director Medical Affairs, Eli Lilly
ANINDITA DAS, Associate Director, Dr. Reddy's Laboratories
MANISH VERMA, Director Medical Affairs, Sanofi
DEBOLINA PARTAP, Associate Vice President and Head Legal, Wockhardt
PARIKSHIT CHAUDHARI, Medical Affairs Manager, Nestle
HANMANT BARKATE, VP & Head- Medical Services, Intas Pharmaceuticals
AMARDEEP UDESHI, Head - Strategy and Market Assessment, Cipla Biologicals
CHANDRA SEKHAR, Vice President Quality, Reliance Life Sciences
SAMBIT PATNAIK, CEO & Medical Director, Clintech India
KAVYA KADAM, Head- Global Clinical Operation, Cipla
SUNIT MAITY, AVP - Product Development, Theramyt Novobiologics
ANAY SHUKLA, Associate, Nishith Desai AssociatePlus many more….
KEY THEMES DISCUSED:-
Global biopharma policy & market trends
The future of biosimilars in India
The evolving biosimilar sector: Trends and Implications
Complex biological models in biosimilar development
Viable extrapolation strategies for biosimilars with special emphasis on TNF antagonists
Effectively communicate the value of biosimilar products to raise confidence in the class
Improving characterization of biosimilars with technology
Create a robust patient services and reimbursement support program for biosimilar products
The future of the biosimilar industry - mapping the evolution and development of the biosimilar sector
Forecasting the financial growth of biosimilars in the global healthcare marketplace
Planning of a biosimilar development project - what to consider from the very beginning
Clinical development strategies for biosimilars
Gaining Better Market Access: Is Commercial CMO Acceptable for the Biosimilars Market?
Regulatory Updates and Development
Be part of a major networking opportunity
Who will you meet:-
CSOs, CMOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, and Senior Scientists from the following roles:
Biopharmaceuticals/ Biotherapeutics, Follow on Biologics/Follow on Proteins, Biologics/Biotechnology/ Biogenerics, Legal Affairs, Intellectual Property, Health Economics, Pricing and Reimbursement, Clinical Immunology, Principal Scientist, Chief Scientific Officer, Process Control and Analytical Technologies, Analytical Characterisation, Regulatory Compliance, Pharmacovigilance, Drug Safety & Risk Management, Quality Affairs/ Quality Control, New Product Development, Process Science, Portfolio Management, Research & Development, Business Development, Business Operations, Scientific Affairs
CONFERENCE BOOKING DETAILS:-
· Early Bird Discounted Price - 1 Delegate Pass (INR 6,000 + Tax (15%) per delegate) - Book and Pay before 09th August 2016 to avail the early bird discounted price. You can simply email or call and book your conference delegate seats on TEL: + 91 44 64536444. Email – amar@virtueinsight.co.in
· Standard Price (10th August 2016) - 1 or 2 Delegates (INR 7,000 + Tax (15%) per delegate) - You can simply email or call and book your conference delegate seats on TEL: + 91 44 64536444. Email – amar@virtueinsight.co.in
· Group Discounts - 3 or 4 Delegates - (INR 6,500 + Tax (15%) per delegate)
· Group Discounts - 5 and above Delegates - (INR 5,500 + Tax (15%) per delegate)
· Spot Registration on the day of the conference - 1 Day Conference - (INR 8,000 + Tax (15%) per delegate)
· Conference Sponsor & Exhibition Stall - Should you wish to Sponsor, or purchase a Exhibition Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to –TEL: + 91 44 64536444. Email - sponsor@virtueinsight.com
I am happy to invite you and your colleagues to be a sponsor/ delegate for our upcoming”9th Biosimilars Congregation” The conference will be held on 22nd September 2016, The Lalit Hotel, Mumbai, India
KEY SPEAKERS:-
DHILEEP KRISHNAMURTHY, Vice President & Head Global R&D API, Piramal Life Sciences
BHASWAT CHAKRABORTY, Senior VP & Chair, Research and Development Core Committee, Cadila
ARUN BHATT, Consultant - Clinical Research & Development
PRITI THAKOR, Associate Director Medical Affairs, Merck
INDRANIL BHATTACHARYA, Associate Director Medical Affairs, Eli Lilly
ANINDITA DAS, Associate Director, Dr. Reddy's Laboratories
MANISH VERMA, Director Medical Affairs, Sanofi
DEBOLINA PARTAP, Associate Vice President and Head Legal, Wockhardt
PARIKSHIT CHAUDHARI, Medical Affairs Manager, Nestle
HANMANT BARKATE, VP & Head- Medical Services, Intas Pharmaceuticals
AMARDEEP UDESHI, Head - Strategy and Market Assessment, Cipla Biologicals
CHANDRA SEKHAR, Vice President Quality, Reliance Life Sciences
SAMBIT PATNAIK, CEO & Medical Director, Clintech India
KAVYA KADAM, Head- Global Clinical Operation, Cipla
SUNIT MAITY, AVP - Product Development, Theramyt Novobiologics
ANAY SHUKLA, Associate, Nishith Desai AssociatePlus many more….
KEY THEMES DISCUSED:-
Global biopharma policy & market trends
The future of biosimilars in India
The evolving biosimilar sector: Trends and Implications
Complex biological models in biosimilar development
Viable extrapolation strategies for biosimilars with special emphasis on TNF antagonists
Effectively communicate the value of biosimilar products to raise confidence in the class
Improving characterization of biosimilars with technology
Create a robust patient services and reimbursement support program for biosimilar products
The future of the biosimilar industry - mapping the evolution and development of the biosimilar sector
Forecasting the financial growth of biosimilars in the global healthcare marketplace
Planning of a biosimilar development project - what to consider from the very beginning
Clinical development strategies for biosimilars
Gaining Better Market Access: Is Commercial CMO Acceptable for the Biosimilars Market?
Regulatory Updates and Development
Be part of a major networking opportunity
Who will you meet:-
CSOs, CMOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, and Senior Scientists from the following roles:
Biopharmaceuticals/ Biotherapeutics, Follow on Biologics/Follow on Proteins, Biologics/Biotechnology/ Biogenerics, Legal Affairs, Intellectual Property, Health Economics, Pricing and Reimbursement, Clinical Immunology, Principal Scientist, Chief Scientific Officer, Process Control and Analytical Technologies, Analytical Characterisation, Regulatory Compliance, Pharmacovigilance, Drug Safety & Risk Management, Quality Affairs/ Quality Control, New Product Development, Process Science, Portfolio Management, Research & Development, Business Development, Business Operations, Scientific Affairs
CONFERENCE BOOKING DETAILS:-
· Early Bird Discounted Price - 1 Delegate Pass (INR 6,000 + Tax (15%) per delegate) - Book and Pay before 09th August 2016 to avail the early bird discounted price. You can simply email or call and book your conference delegate seats on TEL: + 91 44 64536444. Email – amar@virtueinsight.co.in
· Standard Price (10th August 2016) - 1 or 2 Delegates (INR 7,000 + Tax (15%) per delegate) - You can simply email or call and book your conference delegate seats on TEL: + 91 44 64536444. Email – amar@virtueinsight.co.in
· Group Discounts - 3 or 4 Delegates - (INR 6,500 + Tax (15%) per delegate)
· Group Discounts - 5 and above Delegates - (INR 5,500 + Tax (15%) per delegate)
· Spot Registration on the day of the conference - 1 Day Conference - (INR 8,000 + Tax (15%) per delegate)
· Conference Sponsor & Exhibition Stall - Should you wish to Sponsor, or purchase a Exhibition Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to –TEL: + 91 44 64536444. Email - sponsor@virtueinsight.com
